Development and Evaluation of a Culturally Sensitive Structured Diabetes Self-Management Program for People With Type 2 Diabetes Residing in Qatar

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorRagae Dughmosh

About this trial

This study is about helping people in Qatar who have Type 2 Diabetes take better care of their health. Diabetes is a common and growing problem in Qatar, and many people need more support and information to manage it well in their daily lives.

Right now, there is a program called DESMOND in Qatar, but it is only available in a few places and can be expensive to run. It also doesn't always work well in the long term. That's why we are creating a new diabetes education program called PARADIGM-Q. This program will be easier to access, more affordable, and designed to match the culture and needs of people living in Qatar.

The PARADIGM-Q program will teach people how to manage diabetes using real-life examples and group discussions. This method is called Case-Based Learning. It helps people understand their condition better and learn how to make good decisions about food, exercise, medication, and dealing with challenges.

The project will happen in two main phases:

Phase One: Understanding and Creating the Program

In the first part, we'll look at different ways of teaching about diabetes and see if a method called Case-Based Learning (CBL) works well. After that, we'll build a curriculum (a plan for teaching) based on the PARADIGM model. This curriculum, called the PARADIGM-Q program, will use the CBL method to teach. We'll also test this new program with a small group of diabetes educators and people with diabetes to make sure it works well. Their feedback will help me make the program even better.

Phase Two: Testing the Program

In the second part, we'll do a big study using a mix of people from different backgrounds in Qatar who have Type 2 Diabetes. we want to see if the PARADIGM-Q program is better than the program they already have (called DESMOND). we'll look the impact of our new program on different things like how much they know about diabetes, how active they are, their blood sugar levels (HbA1C), and their overall quality of life.

This study could lead to a new standard for diabetes education in Qatar and other countries in the region, helping more people live healthier lives with diabetes.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adults aged 18 to 65 years.

Diagnosed with Type 2 Diabetes Mellitus.

Most recent HbA1c ≥ 8% (within the last 6 months).

Fluent in Arabic and/or English.

Disqualifiers

Diagnosed with any type of diabetes other than Type 2.

Pregnant women.

Presence of major diabetes complications (e.g., renal failure, severe retinopathy, blindness, stroke, heart failure, cancer).

Physical or mental disabilities that would hinder participation in education sessions.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Intervention Name: PARADIGM-Q Diabetes Self-Management Education Program

    Behavioral

    PARADIGM-Q Diabetes Self-Management Education Program This is a culturally sensitive, structured education intervention tailored for adults with Type 2 Diabetes in Qatar. Developed using the PARADIGM model and delivered through a Case-Based Learning (CBL) approach, the program comprises three weekly group sessions of 3.5 hours each. Each session targets key self-management attributes: problem-solving, decision-making, taking action, resource utilization, and patient-provider relationships. The program emphasizes real-life applicability, cultural relevance, and skill-building to support sustainable diabetes self-care.

  • Control Arm (DESMOND): DESMOND Diabetes Self-Management Education Program

    Behavioral

    The DESMOND Diabetes Self-Management Education Program is the standard diabetes education intervention currently offered to newly diagnosed patients with Type 2 Diabetes in Qatar. It is a UK-developed, theory-driven program delivered over two group sessions, each lasting approximately four hours. The program provides structured education on diabetes, lifestyle management, and risk reduction strategies. It does not incorporate case-based learning or cultural tailoring, distinguishing it from the experimental PARADIGM-Q intervention. DESMOND is used here as an active comparator to evaluate the added value of culturally sensitive, problem-based education.

Treatment groups

200 Participants
are divided into 2 treatment groups
Group A: PARADIGM-Q Intervention ArmExperimental treatment 1 intervention
Group B: DESMOND Control ArmActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Change in Glycated Hemoglobin (HbA1c)

Measurement of HbA1c to assess long-term glycemic control.

Time frame
Baseline, 3 months, 6 months, 9 months, 12 months post-intervention

Secondary outcomes

1

Change in Health-Related Quality of Life

Evaluated using the Appraisal of Diabetes Scale (ADS)

Time frame
Baseline and 3, 6, 9, 12 months post-intervention

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Ragae Dughmosh

Lead sponsor

Qatar University

Sponsor institution

Qatar National Research Fund

Collaborator

Hamad Medical Corporation

Collaborator

Primary Health Care Corporation, Qatar

Collaborator

Qatar University

Collaborator

This trial is not recruiting at the moment. You can still explore other options: